Logo-jrip
Submitted: 21 Oct 2024
Revision: 18 May 2025
Accepted: 25 Jul 2025
ePublished: 17 Aug 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. Inpress.
doi: 10.34172/jrip.2025.38673
  Abstract View: 30

Original

Pathological, demographic and laboratory characteristics of lupus nephritis patients in 2017-2019; an experience of a referral laboratory in Northeastern Iran

Mohsen Taghiabadi 1 ORCID logo, Masoumeh Salari 2 ORCID logo, Malihe Saberafsharian 3, Forouzan Amerizadeh 4,5, Maryam Miri 6* ORCID logo

1 Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran
2 Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 Department of Pathology, Islamic Azad University, Mashhad, Iran
4 Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5 Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran
6 Kidney Transplantation Complications Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
*Corresponding Author: Maryam Miri, Email: MiriGhM@mums.ac.ir

Abstract

Introduction: The chronic autoimmune disease systemic lupus erythematosus (SLE) causes inflammation in various body organs, including the skin, joints, kidneys, brain, heart, and lungs.

Objectives: This study aimed to evaluate the correlation between histopathological findings and the demographic and laboratory data of patients with lupus nephritis.

Patients and Methods: This descriptive-analytical study was conducted over a 2-year period starting in 2017 at the Northeast Iran in a referral laboratory located in Mashhad, Iran. Patients with a definitive diagnosis of lupus nephritis were retrospectively selected and classified according to the 2003 ISN/RPS classification system. Demographic and laboratory data were obtained from patients’ documents, para-clinical findings in their files, and through phone interviews.

Results: Seventy-one cases with a definitive pathological diagnosis of lupus nephritis were included. The most common class of lupus nephritis was class IV (diffuse type), followed by class III (focal type) (43.7% and 21.1%, respectively). The incidence of malar rash was reported in 100% of class II, 73.3% of class III, 51.6% of class IV, and 64.3% of class V patients (p=0.05). Additionally, the incidence of hypocomplementemia was reported in 22.2% of class II, 40% of class III, 69% of class IV, and 50% of class V patients (P=0.05). The presence of anti-beta-2 glycoprotein I antibody was reported in 21.4% of cases with class V lupus nephritis too.

Conclusion: The most common classes of lupus nephritis were class IV and class III. Among the demographic, laboratory, and clinical characteristics, lupus nephritis was significantly associated with malar rash and hypocomplementemia.


Implication for health policy/practice/research/medical education:

This study evaluated the relationship between pathology findings and demographic/laboratory data of lupus nephritis patients. Conducted over two years in Northeast Iran, it included 71 patients. The most common types were class IV (43.7%) and class III (21.1%). Significant associations were found between lupus nephritis and factors like malar rash, hypocomplementemia, and anti-beta-2 glycoprotein I antibody. The findings highlight the prevalence of class IV and III lupus nephritis and their clinical correlations.

Please cite this paper as: Taghiabadi M, Salari M, Saberafsharian M, Amerizadeh F, Miri M Pathological, demographic and laboratory characteristics of lupus nephritis patients in 2017-2019; an experience of a referral laboratory in Northeastern Iran. J Renal Inj Prev. 2025; x(x): e38673. doi: 10.34172/jrip.2025.38673.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 31

Your browser does not support the canvas element.


PDF Download: 0

Your browser does not support the canvas element.